Tag

Medical Products

All articles tagged with #medical products

Investors Brace for Market Stress as Fed Signals More Hikes Ahead
business2 years ago

Investors Brace for Market Stress as Fed Signals More Hikes Ahead

Dow Jones futures fell modestly Thursday morning, along with S&P 500 futures and Nasdaq futures. China cut rates amid fresh disappointing economic data. The stock market rally showed resilience Wednesday. Indexes initially gave up ground on a surprisingly hawkish Federal Reserve rate-hike outlook, but closed mixed on relatively dovish comments from Fed chief Jerome Powell. A slew of medical products and systems makers flashed buy signals Wednesday, after Dow Jones insurance giant UnitedHealth warned that patients are spending more on medical procedures. Homebuilder Lennar reported earnings after the close.

Fed's decision causes market turbulence and uncertainty.
finance2 years ago

Fed's decision causes market turbulence and uncertainty.

The stock market rally showed resilience Wednesday despite a hawkish Federal Reserve rate-hike outlook, with indexes closing mixed on relatively dovish comments from Fed chief Jerome Powell. China cut rates amid fresh disappointing economic data. Homebuilder Lennar reported earnings after the close. A slew of medical products and systems makers flashed buy signals Wednesday, after Dow Jones insurance giant UnitedHealth warned that patients are spending more on medical procedures.

FDA Implements Modernized Clinical Trial Standards with E6(R3) GCP.
health2 years ago

FDA Implements Modernized Clinical Trial Standards with E6(R3) GCP.

The FDA has released draft guidance with updated recommendations for good clinical practices (GCPs) to modernize the design and conduct of clinical trials, making them more efficient and flexible without compromising data integrity or participant protections. The draft guidance is aimed at incorporating rapidly developing technological and methodological innovations into the clinical trial enterprise and encouraging the use of innovative trial designs and health technologies. The FDA is requesting feedback on the draft recommendations and how they should be applied to increasingly diverse trial types and data sources.